Try our beta test site
1 study found for:    GSK Anti-IL5 MHE 104317 Mepolizumab
Show Display Options
Rank Status Study
1 Available An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Mepolizumab

Study has passed its completion date and status has not been verified in more than two years.